Latest news
China approves therapy tackling FGFR inhibitor resistance in biliary cancer - FirstWord PharmaFirstWord Pharma · Fri, 07 Aug 2026 13:02:10 GMTYochanra® approved in China as world-first for FGFR inhibitor-resistant cancer - European Pharmaceutical ReviewEuropean Pharmaceutical Review · Fri, 07 Aug 2026 12:25:36 GMTTransThera's resistant biliary cancer drug cleared in China - pharmaphorumpharmaphorum · Fri, 07 Aug 2026 11:50:30 GMTROHM's New 2nd-generation Terahertz Wave Oscillation Device Delivers 4 Times Higher Output Power - The Manila TimesThe Manila Times · Fri, 07 Aug 2026 07:20:06 GMTYochanra®, the World's First Innovative Drug to Overcome FGFR Inhibitor Resistance, Makes Its Global Debut in China - Yahoo Finance AustraliaYahoo Finance Australia · Fri, 07 Aug 2026 06:44:00 GMT